Brent L. Saunders, CEO and Chairman of Bausch & Lomb Corp ($BLCO), made two open market purchases of $BLCO shares worth a total of $500,000 over the past year, with the latest on March 6, 2026. These rank 841st among 4,983 insiders, below the average purchase of $1.5 million across 3.3 transactions. He also sold $SPRY shares of ARS Pharmaceuticals ($SPRY) once for $1.7 million on May 20, 2025, ranking 3,794th out of 11,678 insiders, under the average sale of $8.6 million across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 14700 | $0.00 | 981,275.0000 | 354,318,198 | 1.52% | 0.00% |
| March 6, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 14700 | $17.14 | 966,575.0000 | 354,318,198 | 1.54% | 0.00% |
| Feb. 27, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 24649 | $18.30 | 951,875.0000 | 354,318,198 | 2.52% | 0.01% |
| Feb. 26, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 22059 | $18.49 | 976,524.0000 | 354,318,198 | 2.21% | 0.01% |
| Feb. 25, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 327102 | $0.00 | 998,583.0000 | 354,318,198 | 48.71% | 0.09% |
| Feb. 23, 2026 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 65444 | $17.99 | 671,481.0000 | 354,318,198 | 8.88% | 0.02% |
| Aug. 5, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 4231 | $14.44 | 736,925.0000 | 352,470,796 | 0.57% | 0.00% |
| July 21, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Performance Stock Units | 150000 | $0.00 | 900,000.0000 | 352,470,796 | 20.00% | 0.04% |
| June 25, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| June 16, 2025 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | A | Class A Common Stock | 73051 | $0.00 | 8,797,771.0000 | 125,246,286 | 0.84% | 0.06% |
| May 22, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 22000 | $11.28 | 719,156.0000 | 352,470,796 | 3.16% | 0.01% |
| May 22, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 22000 | $0.00 | 741,156.0000 | 352,470,796 | 3.06% | 0.01% |
| May 20, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Not found | S | Common Stock | 120000 | $14.25 | 0.0000 | 102,390,828 | 100.00% | 0.12% |
| May 20, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Not found | M | Common Stock | 120000 | $1.01 | 120,000.0000 | 102,390,828 | 9999.99% | 0.12% |
| May 20, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Not found | M | Stock Option (Right to Buy) | 120000 | $0.00 | 470,950.0000 | 102,390,828 | 20.31% | 0.12% |
| Feb. 26, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Non-Qualified Stock Options (right to purchase) | 600858 | $0.00 | 600,858.0000 | 352,470,796 | 9999.99% | 0.17% |
| Feb. 26, 2025 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 168168 | $0.00 | 697,156.0000 | 352,470,796 | 31.79% | 0.05% |
| Dec. 23, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 24649 | $17.83 | 528,988.0000 | 353,900,000 | 4.45% | 0.01% |
| Dec. 23, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | F | Common Shares, No Par Value | 73782 | $17.83 | 553,637.0000 | 353,900,000 | 11.76% | 0.02% |
| Aug. 12, 2024 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | P | Class A Common Stock | 40450 | $1.08 | 8,724,720.0000 | 123,993,785 | 0.47% | 0.03% |
| Aug. 5, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | A | Common Shares, No Par Value | 32250 | $0.00 | 627,419.0000 | 350,500,000 | 5.42% | 0.01% |
| Aug. 5, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chairman of the Board | P | Common Shares, No Par Value | 32250 | $15.66 | 595,169.0000 | 350,500,000 | 5.73% | 0.01% |
| June 30, 2022 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | F | Class A Common Stock | 3076 | $12.86 | 8,623,617.0000 | 150,598,047 | 0.04% | 0.00% |
| March 31, 2022 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | F | Class A Common Stock | 3711 | $16.88 | 8,626,693.0000 | 150,598,047 | 0.04% | 0.00% |
| July 8, 2024 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | A | Class A Common Stock | 78534 | $0.00 | 8,684,270.0000 | 123,993,785 | 0.91% | 0.06% |
| Dec. 30, 2022 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | F | Class A Common Stock | 2167 | $9.10 | 8,619,284.0000 | 150,598,047 | 0.03% | 0.00% |
| Sept. 30, 2022 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | F | Class A Common Stock | 2166 | $11.79 | 8,621,451.0000 | 150,598,047 | 0.03% | 0.00% |
| Feb. 3, 2023 | Beauty Health Co | $SKIN | SAUNDERS BRENT L | Other | F | Class A Common Stock | 13548 | $12.90 | 8,605,736.0000 | 132,214,695 | 0.16% | 0.01% |
| June 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| Feb. 28, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chair | A | Non-Qualified Stock Options (right to purchase) | 569105 | $0.00 | 569,105.0000 | 350,500,000 | 9999.99% | 0.16% |
| Feb. 28, 2024 | Bausch & Lomb Corp | $BLCO | SAUNDERS BRENT L | CEO and Chair | A | Common Shares, No Par Value | 187919 | $0.00 | 562,919.0000 | 350,500,000 | 50.11% | 0.05% |
| June 27, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | SAUNDERS BRENT L | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |